Marianne Scheel Fjording

Marianne Scheel Fjording, MSc, PhD, is the CEO and founder of Biolyzr, an independent consultant company specializing in bioanalysis excellence. The consultancy covers all aspects of bioanalytical activities, including bioanalytical strategy, project scoping and management, audits, compliance as well as CRO selection and monitoring.

Prior to founding Biolyzr, Marianne was Scientific Director at Novo Nordisk and Scientific Officer and Executive Director at BioAgilytix (both Copenhagen, Denmark), where she worked with regulated bioanalytical assay validation. Her experience is within large molecules and immunoassays. Marianne was a member of the Expert working group (EWG) for the newly implemented ICH M10 guideline as a representative for PhRMA.

Marianne has been active in the EBF as a member and part of the steering committee and the organizing committee for workshops and annual symposiums.

Marianne has a Master of Science degree in biochemistry from Copenhagen University (Denmark), a PhD in intracellular signaling and more than 25 years of experience within pharmaceutical companies.

What three things would you take if you were stranded on a desert island?

• My family
• A good book
• Sunscreen

If you weren’t a bioanalyst, what would you be?

• Gardener growing tomatoes

What is your favorite city?

• Rome

Why have you decided to become a Zone Leader?

I love to share my passion and experience about the complex world of regulated bioanalytical strategies. With all the new modalities in drug development, this is an exciting journey.